M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Wall Street
Price Targets

Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC

Wall Street analysts forecast Middle East Pharmaceutical Industries Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 133.62 SAR with a low forecast of 132.31 SAR and a high forecast of 137.55 SAR.

Lowest
Price Target
132.31 SAR
9% Upside
Average
Price Target
133.62 SAR
10% Upside
Highest
Price Target
137.55 SAR
13% Upside
Middle East Pharmaceutical Industries Company SJSC Competitors:
Price Targets
MMQ
Mind Medicine (MindMed) Inc
236% Upside
GLAND
Gland Pharma Ltd
0% Upside
CIPLA
Cipla Ltd
12% Upside
ETON
Eton Pharmaceuticals Inc
18% Upside
MDWD
Mediwound Ltd
84% Upside
4565
Sosei Group Corp
90% Upside
LUPIN
Lupin Ltd
7% Upside
BSEM
Biostem Technologies Inc
138% Upside

Revenue
Forecast

Revenue Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 9%. The projected CAGR for the next 3 years is 15%.

9%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is 4%. The projected CAGR for the next 3 years is 21%.

4%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Middle East Pharmaceutical Industries Company SJSC

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is 0%. The projected CAGR for the next 3 years is 24%.

0%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Middle East Pharmaceutical Industries Company SJSC's stock price target?
Price Target
133.62 SAR

According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 133.62 SAR with a low forecast of 132.31 SAR and a high forecast of 137.55 SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Revenue forecast?
Projected CAGR
15%

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's revenue is 9%. The projected CAGR for the next 3 years is 15%.

What is Middle East Pharmaceutical Industries Company SJSC's Operating Income forecast?
Projected CAGR
21%

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's operating income is 4%. The projected CAGR for the next 3 years is 21%.

What is Middle East Pharmaceutical Industries Company SJSC's Net Income forecast?
Projected CAGR
24%

For the last 2 years the compound annual growth rate for Middle East Pharmaceutical Industries Company SJSC's net income is 0%. The projected CAGR for the next 3 years is 24%.

Back to Top